Mealey's (April 5, 2022, 8:58 AM EDT) -- NEWARK, N.J. — A New Jersey federal judge on March 30 said four consumers lack standing to bring a variety of class claims against 10 manufacturers of the diabetes drug metformin due to alleged contamination by the potential carcinogen N-nitrosodimethylamine (NDMA) but dismissed some claims brought by a third-party payer while allowing other claims to remain....